Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Supply, Demand and Key Producers, 2023-2029
The global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment market size is expected to reach $ 207.3 million by 2029, rising at a market growth of 10.5% CAGR during the forecast period (2023-2029).
The paroxysmal nocturnal hemoglobinuria (PNH) treatment market is a growing area focused on developing innovative drugs and treatments to improve the quality of life of patients with PNH. The market covers various treatment options, including monoclonal antibody therapies, immunosuppressive drugs, and hematopoietic stem cell transplantation, aimed at alleviating symptoms, controlling hemolysis, and improving blood abnormalities in PNH patients, thus providing better clinical outcomes. As scientific research continues to advance and medical technology continues to improve, the PNH treatment market is expected to continue to expand, providing patients with more treatment options and the opportunity to improve survival rates.
Paroxysmal nocturnal hemoglobinuria (PNH) is a non-malignant clonal disease caused by acquired somatic PIG-A gene (phosphotidyl inositol glycan complementation group A) mutations in one or several hematopoietic stem cells. Disease, PIG-A mutation causes abnormal synthesis of glycosyl phosphatidyl inositol (GPI), resulting in the loss of a group of membrane proteins anchored to the cell membrane by GPI, including CD16, CD55, CD59, etc., which are mainly clinically It manifests as chronic intravascular hemolysis, hematopoietic failure and recurrent thrombosis.
This report studies the global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment total production and demand, 2018-2029, (K Units)
Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment total production value, 2018-2029, (USD Million)
Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment domestic production, consumption, key domestic manufacturers and share
Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amoun Pharmaceuticals, EIPICO, Minapharm Pharmaceuticals, Pharco Pharmaceuticals, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Akari Therapeutics, Amgen and CSL Behring, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, By Region:
1. How big is the global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment market?
2. What is the demand of the global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment market?
3. What is the year over year growth of the global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment market?
4. What is the production and production value of the global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment market?
5. Who are the key producers in the global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment market?
The paroxysmal nocturnal hemoglobinuria (PNH) treatment market is a growing area focused on developing innovative drugs and treatments to improve the quality of life of patients with PNH. The market covers various treatment options, including monoclonal antibody therapies, immunosuppressive drugs, and hematopoietic stem cell transplantation, aimed at alleviating symptoms, controlling hemolysis, and improving blood abnormalities in PNH patients, thus providing better clinical outcomes. As scientific research continues to advance and medical technology continues to improve, the PNH treatment market is expected to continue to expand, providing patients with more treatment options and the opportunity to improve survival rates.
Paroxysmal nocturnal hemoglobinuria (PNH) is a non-malignant clonal disease caused by acquired somatic PIG-A gene (phosphotidyl inositol glycan complementation group A) mutations in one or several hematopoietic stem cells. Disease, PIG-A mutation causes abnormal synthesis of glycosyl phosphatidyl inositol (GPI), resulting in the loss of a group of membrane proteins anchored to the cell membrane by GPI, including CD16, CD55, CD59, etc., which are mainly clinically It manifests as chronic intravascular hemolysis, hematopoietic failure and recurrent thrombosis.
This report studies the global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment total production and demand, 2018-2029, (K Units)
Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment total production value, 2018-2029, (USD Million)
Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment domestic production, consumption, key domestic manufacturers and share
Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amoun Pharmaceuticals, EIPICO, Minapharm Pharmaceuticals, Pharco Pharmaceuticals, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Akari Therapeutics, Amgen and CSL Behring, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Monoclonal Antibodies Therapy
- Immunosuppressive Drugs
- Hematopoietic Stem Cell Transplantation
- Hospital
- Clinic
- Other
- Amoun Pharmaceuticals
- EIPICO
- Minapharm Pharmaceuticals
- Pharco Pharmaceuticals
- Alexion Pharmaceuticals
- Alnylam Pharmaceuticals
- Akari Therapeutics
- Amgen
- CSL Behring
- Bioverativ
- F. Hoffmann-La Roche Ltd
- Novartis AG
- Amgen Inc
- Teva Pharmaceutical
- Abbott
1. How big is the global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment market?
2. What is the demand of the global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment market?
3. What is the year over year growth of the global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment market?
4. What is the production and production value of the global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment market?
5. Who are the key producers in the global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment market?
1 SUPPLY SUMMARY
1.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Introduction
1.2 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Supply & Forecast
1.2.1 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value (2018 & 2022 & 2029)
1.2.2 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2029)
1.2.3 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Pricing Trends (2018-2029)
1.3 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Region (Based on Production Site)
1.3.1 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Region (2018-2029)
1.3.2 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Region (2018-2029)
1.3.3 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Region (2018-2029)
1.3.4 North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2029)
1.3.5 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2029)
1.3.6 China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2029)
1.3.7 Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Major Market Trends
2 DEMAND SUMMARY
2.1 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Demand (2018-2029)
2.2 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption by Region
2.2.1 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption by Region (2018-2023)
2.2.2 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029)
2.4 China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029)
2.5 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029)
2.6 Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029)
2.7 South Korea Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029)
2.8 ASEAN Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029)
2.9 India Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029)
3 WORLD PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Manufacturer (2018-2023)
3.2 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Manufacturer (2018-2023)
3.3 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Manufacturer (2018-2023)
3.4 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment in 2022
3.5.3 Global Concentration Ratios (CR8) for Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment in 2022
3.6 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market: Overall Company Footprint Analysis
3.6.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market: Region Footprint
3.6.2 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market: Company Product Type Footprint
3.6.3 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Comparison
4.1.1 United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Comparison
4.2.1 United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption Comparison
4.3.1 United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value (2018-2023)
4.4.3 United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2023)
4.5 China Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Manufacturers and Market Share
4.5.1 China Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value (2018-2023)
4.5.3 China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2023)
4.6 Rest of World Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibodies Therapy
5.2.2 Immunosuppressive Drugs
5.2.3 Hematopoietic Stem Cell Transplantation
5.3 Market Segment by Type
5.3.1 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Type (2018-2029)
5.3.2 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Type (2018-2029)
5.3.3 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Application (2018-2029)
6.3.2 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Application (2018-2029)
6.3.3 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Amoun Pharmaceuticals
7.1.1 Amoun Pharmaceuticals Details
7.1.2 Amoun Pharmaceuticals Major Business
7.1.3 Amoun Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.1.4 Amoun Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Amoun Pharmaceuticals Recent Developments/Updates
7.1.6 Amoun Pharmaceuticals Competitive Strengths & Weaknesses
7.2 EIPICO
7.2.1 EIPICO Details
7.2.2 EIPICO Major Business
7.2.3 EIPICO Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.2.4 EIPICO Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 EIPICO Recent Developments/Updates
7.2.6 EIPICO Competitive Strengths & Weaknesses
7.3 Minapharm Pharmaceuticals
7.3.1 Minapharm Pharmaceuticals Details
7.3.2 Minapharm Pharmaceuticals Major Business
7.3.3 Minapharm Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.3.4 Minapharm Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Minapharm Pharmaceuticals Recent Developments/Updates
7.3.6 Minapharm Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Pharco Pharmaceuticals
7.4.1 Pharco Pharmaceuticals Details
7.4.2 Pharco Pharmaceuticals Major Business
7.4.3 Pharco Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.4.4 Pharco Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Pharco Pharmaceuticals Recent Developments/Updates
7.4.6 Pharco Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Alexion Pharmaceuticals
7.5.1 Alexion Pharmaceuticals Details
7.5.2 Alexion Pharmaceuticals Major Business
7.5.3 Alexion Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.5.4 Alexion Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Alexion Pharmaceuticals Recent Developments/Updates
7.5.6 Alexion Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Alnylam Pharmaceuticals
7.6.1 Alnylam Pharmaceuticals Details
7.6.2 Alnylam Pharmaceuticals Major Business
7.6.3 Alnylam Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.6.4 Alnylam Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Alnylam Pharmaceuticals Recent Developments/Updates
7.6.6 Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Akari Therapeutics
7.7.1 Akari Therapeutics Details
7.7.2 Akari Therapeutics Major Business
7.7.3 Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.7.4 Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Akari Therapeutics Recent Developments/Updates
7.7.6 Akari Therapeutics Competitive Strengths & Weaknesses
7.8 Amgen
7.8.1 Amgen Details
7.8.2 Amgen Major Business
7.8.3 Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.8.4 Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Amgen Recent Developments/Updates
7.8.6 Amgen Competitive Strengths & Weaknesses
7.9 CSL Behring
7.9.1 CSL Behring Details
7.9.2 CSL Behring Major Business
7.9.3 CSL Behring Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.9.4 CSL Behring Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 CSL Behring Recent Developments/Updates
7.9.6 CSL Behring Competitive Strengths & Weaknesses
7.10 Bioverativ
7.10.1 Bioverativ Details
7.10.2 Bioverativ Major Business
7.10.3 Bioverativ Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.10.4 Bioverativ Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Bioverativ Recent Developments/Updates
7.10.6 Bioverativ Competitive Strengths & Weaknesses
7.11 F. Hoffmann-La Roche Ltd
7.11.1 F. Hoffmann-La Roche Ltd Details
7.11.2 F. Hoffmann-La Roche Ltd Major Business
7.11.3 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.11.4 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.11.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.12 Novartis AG
7.12.1 Novartis AG Details
7.12.2 Novartis AG Major Business
7.12.3 Novartis AG Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.12.4 Novartis AG Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Novartis AG Recent Developments/Updates
7.12.6 Novartis AG Competitive Strengths & Weaknesses
7.13 Amgen Inc
7.13.1 Amgen Inc Details
7.13.2 Amgen Inc Major Business
7.13.3 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.13.4 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Amgen Inc Recent Developments/Updates
7.13.6 Amgen Inc Competitive Strengths & Weaknesses
7.14 Teva Pharmaceutical
7.14.1 Teva Pharmaceutical Details
7.14.2 Teva Pharmaceutical Major Business
7.14.3 Teva Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.14.4 Teva Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Teva Pharmaceutical Recent Developments/Updates
7.14.6 Teva Pharmaceutical Competitive Strengths & Weaknesses
7.15 Abbott
7.15.1 Abbott Details
7.15.2 Abbott Major Business
7.15.3 Abbott Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.15.4 Abbott Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Abbott Recent Developments/Updates
7.15.6 Abbott Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Industry Chain
8.2 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Upstream Analysis
8.2.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Core Raw Materials
8.2.2 Main Manufacturers of Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Mode
8.6 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Procurement Model
8.7 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Industry Sales Model and Sales Channels
8.7.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Sales Model
8.7.2 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Introduction
1.2 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Supply & Forecast
1.2.1 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value (2018 & 2022 & 2029)
1.2.2 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2029)
1.2.3 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Pricing Trends (2018-2029)
1.3 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Region (Based on Production Site)
1.3.1 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Region (2018-2029)
1.3.2 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Region (2018-2029)
1.3.3 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Region (2018-2029)
1.3.4 North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2029)
1.3.5 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2029)
1.3.6 China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2029)
1.3.7 Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Major Market Trends
2 DEMAND SUMMARY
2.1 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Demand (2018-2029)
2.2 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption by Region
2.2.1 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption by Region (2018-2023)
2.2.2 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029)
2.4 China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029)
2.5 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029)
2.6 Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029)
2.7 South Korea Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029)
2.8 ASEAN Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029)
2.9 India Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029)
3 WORLD PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Manufacturer (2018-2023)
3.2 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Manufacturer (2018-2023)
3.3 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Manufacturer (2018-2023)
3.4 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment in 2022
3.5.3 Global Concentration Ratios (CR8) for Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment in 2022
3.6 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market: Overall Company Footprint Analysis
3.6.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market: Region Footprint
3.6.2 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market: Company Product Type Footprint
3.6.3 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Comparison
4.1.1 United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Comparison
4.2.1 United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption Comparison
4.3.1 United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value (2018-2023)
4.4.3 United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2023)
4.5 China Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Manufacturers and Market Share
4.5.1 China Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value (2018-2023)
4.5.3 China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2023)
4.6 Rest of World Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibodies Therapy
5.2.2 Immunosuppressive Drugs
5.2.3 Hematopoietic Stem Cell Transplantation
5.3 Market Segment by Type
5.3.1 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Type (2018-2029)
5.3.2 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Type (2018-2029)
5.3.3 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Application (2018-2029)
6.3.2 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Application (2018-2029)
6.3.3 World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Amoun Pharmaceuticals
7.1.1 Amoun Pharmaceuticals Details
7.1.2 Amoun Pharmaceuticals Major Business
7.1.3 Amoun Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.1.4 Amoun Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Amoun Pharmaceuticals Recent Developments/Updates
7.1.6 Amoun Pharmaceuticals Competitive Strengths & Weaknesses
7.2 EIPICO
7.2.1 EIPICO Details
7.2.2 EIPICO Major Business
7.2.3 EIPICO Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.2.4 EIPICO Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 EIPICO Recent Developments/Updates
7.2.6 EIPICO Competitive Strengths & Weaknesses
7.3 Minapharm Pharmaceuticals
7.3.1 Minapharm Pharmaceuticals Details
7.3.2 Minapharm Pharmaceuticals Major Business
7.3.3 Minapharm Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.3.4 Minapharm Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Minapharm Pharmaceuticals Recent Developments/Updates
7.3.6 Minapharm Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Pharco Pharmaceuticals
7.4.1 Pharco Pharmaceuticals Details
7.4.2 Pharco Pharmaceuticals Major Business
7.4.3 Pharco Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.4.4 Pharco Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Pharco Pharmaceuticals Recent Developments/Updates
7.4.6 Pharco Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Alexion Pharmaceuticals
7.5.1 Alexion Pharmaceuticals Details
7.5.2 Alexion Pharmaceuticals Major Business
7.5.3 Alexion Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.5.4 Alexion Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Alexion Pharmaceuticals Recent Developments/Updates
7.5.6 Alexion Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Alnylam Pharmaceuticals
7.6.1 Alnylam Pharmaceuticals Details
7.6.2 Alnylam Pharmaceuticals Major Business
7.6.3 Alnylam Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.6.4 Alnylam Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Alnylam Pharmaceuticals Recent Developments/Updates
7.6.6 Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Akari Therapeutics
7.7.1 Akari Therapeutics Details
7.7.2 Akari Therapeutics Major Business
7.7.3 Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.7.4 Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Akari Therapeutics Recent Developments/Updates
7.7.6 Akari Therapeutics Competitive Strengths & Weaknesses
7.8 Amgen
7.8.1 Amgen Details
7.8.2 Amgen Major Business
7.8.3 Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.8.4 Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Amgen Recent Developments/Updates
7.8.6 Amgen Competitive Strengths & Weaknesses
7.9 CSL Behring
7.9.1 CSL Behring Details
7.9.2 CSL Behring Major Business
7.9.3 CSL Behring Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.9.4 CSL Behring Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 CSL Behring Recent Developments/Updates
7.9.6 CSL Behring Competitive Strengths & Weaknesses
7.10 Bioverativ
7.10.1 Bioverativ Details
7.10.2 Bioverativ Major Business
7.10.3 Bioverativ Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.10.4 Bioverativ Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Bioverativ Recent Developments/Updates
7.10.6 Bioverativ Competitive Strengths & Weaknesses
7.11 F. Hoffmann-La Roche Ltd
7.11.1 F. Hoffmann-La Roche Ltd Details
7.11.2 F. Hoffmann-La Roche Ltd Major Business
7.11.3 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.11.4 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.11.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.12 Novartis AG
7.12.1 Novartis AG Details
7.12.2 Novartis AG Major Business
7.12.3 Novartis AG Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.12.4 Novartis AG Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Novartis AG Recent Developments/Updates
7.12.6 Novartis AG Competitive Strengths & Weaknesses
7.13 Amgen Inc
7.13.1 Amgen Inc Details
7.13.2 Amgen Inc Major Business
7.13.3 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.13.4 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Amgen Inc Recent Developments/Updates
7.13.6 Amgen Inc Competitive Strengths & Weaknesses
7.14 Teva Pharmaceutical
7.14.1 Teva Pharmaceutical Details
7.14.2 Teva Pharmaceutical Major Business
7.14.3 Teva Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.14.4 Teva Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Teva Pharmaceutical Recent Developments/Updates
7.14.6 Teva Pharmaceutical Competitive Strengths & Weaknesses
7.15 Abbott
7.15.1 Abbott Details
7.15.2 Abbott Major Business
7.15.3 Abbott Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
7.15.4 Abbott Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Abbott Recent Developments/Updates
7.15.6 Abbott Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Industry Chain
8.2 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Upstream Analysis
8.2.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Core Raw Materials
8.2.2 Main Manufacturers of Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Mode
8.6 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Procurement Model
8.7 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Industry Sales Model and Sales Channels
8.7.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Sales Model
8.7.2 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share by Region (2018-2023)
Table 9. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share by Region (2024-2029)
Table 10. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Major Market Trends
Table 13. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Producers in 2022
Table 18. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Producers in 2022
Table 20. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Company Evaluation Quadrant
Table 22. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Site of Key Manufacturer
Table 24. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market: Company Product Type Footprint
Table 25. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market: Company Product Application Footprint
Table 26. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Competitive Factors
Table 27. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment New Entrant and Capacity Expansion Plans
Table 28. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share (2018-2023)
Table 37. China Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share (2018-2023)
Table 47. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Type (2018-2023) & (K Units)
Table 49. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Type (2024-2029) & (K Units)
Table 50. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Type (2018-2023) & (USD Million)
Table 51. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Type (2024-2029) & (USD Million)
Table 52. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Amoun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. Amoun Pharmaceuticals Major Business
Table 63. Amoun Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 64. Amoun Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Amoun Pharmaceuticals Recent Developments/Updates
Table 66. Amoun Pharmaceuticals Competitive Strengths & Weaknesses
Table 67. EIPICO Basic Information, Manufacturing Base and Competitors
Table 68. EIPICO Major Business
Table 69. EIPICO Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 70. EIPICO Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. EIPICO Recent Developments/Updates
Table 72. EIPICO Competitive Strengths & Weaknesses
Table 73. Minapharm Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Minapharm Pharmaceuticals Major Business
Table 75. Minapharm Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 76. Minapharm Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Minapharm Pharmaceuticals Recent Developments/Updates
Table 78. Minapharm Pharmaceuticals Competitive Strengths & Weaknesses
Table 79. Pharco Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Pharco Pharmaceuticals Major Business
Table 81. Pharco Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 82. Pharco Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Pharco Pharmaceuticals Recent Developments/Updates
Table 84. Pharco Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Alexion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Alexion Pharmaceuticals Major Business
Table 87. Alexion Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 88. Alexion Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Alexion Pharmaceuticals Recent Developments/Updates
Table 90. Alexion Pharmaceuticals Competitive Strengths & Weaknesses
Table 91. Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Alnylam Pharmaceuticals Major Business
Table 93. Alnylam Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 94. Alnylam Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Alnylam Pharmaceuticals Recent Developments/Updates
Table 96. Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
Table 97. Akari Therapeutics Basic Information, Manufacturing Base and Competitors
Table 98. Akari Therapeutics Major Business
Table 99. Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 100. Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Akari Therapeutics Recent Developments/Updates
Table 102. Akari Therapeutics Competitive Strengths & Weaknesses
Table 103. Amgen Basic Information, Manufacturing Base and Competitors
Table 104. Amgen Major Business
Table 105. Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 106. Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Amgen Recent Developments/Updates
Table 108. Amgen Competitive Strengths & Weaknesses
Table 109. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 110. CSL Behring Major Business
Table 111. CSL Behring Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 112. CSL Behring Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. CSL Behring Recent Developments/Updates
Table 114. CSL Behring Competitive Strengths & Weaknesses
Table 115. Bioverativ Basic Information, Manufacturing Base and Competitors
Table 116. Bioverativ Major Business
Table 117. Bioverativ Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 118. Bioverativ Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Bioverativ Recent Developments/Updates
Table 120. Bioverativ Competitive Strengths & Weaknesses
Table 121. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 122. F. Hoffmann-La Roche Ltd Major Business
Table 123. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 124. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 126. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 127. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 128. Novartis AG Major Business
Table 129. Novartis AG Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 130. Novartis AG Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Novartis AG Recent Developments/Updates
Table 132. Novartis AG Competitive Strengths & Weaknesses
Table 133. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 134. Amgen Inc Major Business
Table 135. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 136. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Amgen Inc Recent Developments/Updates
Table 138. Amgen Inc Competitive Strengths & Weaknesses
Table 139. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. Teva Pharmaceutical Major Business
Table 141. Teva Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 142. Teva Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Teva Pharmaceutical Recent Developments/Updates
Table 144. Abbott Basic Information, Manufacturing Base and Competitors
Table 145. Abbott Major Business
Table 146. Abbott Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 147. Abbott Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Upstream (Raw Materials)
Table 149. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Typical Customers
Table 150. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Typical Distributors
LIST OF FIGURE
Figure 1. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Picture
Figure 2. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2029) & (K Units)
Figure 5. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2029) & (K Units)
Figure 10. China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2029) & (K Units)
Figure 12. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Markets in 2022
Figure 26. United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share 2022
Figure 32. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share by Type in 2022
Figure 34. Monoclonal Antibodies Therapy
Figure 35. Immunosuppressive Drugs
Figure 36. Hematopoietic Stem Cell Transplantation
Figure 37. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share by Type (2018-2029)
Figure 38. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share by Type (2018-2029)
Figure 39. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Clinic
Figure 44. Other
Figure 45. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share by Application (2018-2029)
Figure 46. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share by Application (2018-2029)
Figure 47. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Industry Chain
Figure 49. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Procurement Model
Figure 50. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Sales Model
Figure 51. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Table 1. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share by Region (2018-2023)
Table 9. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share by Region (2024-2029)
Table 10. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Major Market Trends
Table 13. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Producers in 2022
Table 18. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Producers in 2022
Table 20. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Company Evaluation Quadrant
Table 22. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Site of Key Manufacturer
Table 24. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market: Company Product Type Footprint
Table 25. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market: Company Product Application Footprint
Table 26. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Competitive Factors
Table 27. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment New Entrant and Capacity Expansion Plans
Table 28. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share (2018-2023)
Table 37. China Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share (2018-2023)
Table 47. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Type (2018-2023) & (K Units)
Table 49. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Type (2024-2029) & (K Units)
Table 50. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Type (2018-2023) & (USD Million)
Table 51. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Type (2024-2029) & (USD Million)
Table 52. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Amoun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. Amoun Pharmaceuticals Major Business
Table 63. Amoun Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 64. Amoun Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Amoun Pharmaceuticals Recent Developments/Updates
Table 66. Amoun Pharmaceuticals Competitive Strengths & Weaknesses
Table 67. EIPICO Basic Information, Manufacturing Base and Competitors
Table 68. EIPICO Major Business
Table 69. EIPICO Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 70. EIPICO Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. EIPICO Recent Developments/Updates
Table 72. EIPICO Competitive Strengths & Weaknesses
Table 73. Minapharm Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Minapharm Pharmaceuticals Major Business
Table 75. Minapharm Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 76. Minapharm Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Minapharm Pharmaceuticals Recent Developments/Updates
Table 78. Minapharm Pharmaceuticals Competitive Strengths & Weaknesses
Table 79. Pharco Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Pharco Pharmaceuticals Major Business
Table 81. Pharco Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 82. Pharco Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Pharco Pharmaceuticals Recent Developments/Updates
Table 84. Pharco Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Alexion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Alexion Pharmaceuticals Major Business
Table 87. Alexion Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 88. Alexion Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Alexion Pharmaceuticals Recent Developments/Updates
Table 90. Alexion Pharmaceuticals Competitive Strengths & Weaknesses
Table 91. Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Alnylam Pharmaceuticals Major Business
Table 93. Alnylam Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 94. Alnylam Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Alnylam Pharmaceuticals Recent Developments/Updates
Table 96. Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
Table 97. Akari Therapeutics Basic Information, Manufacturing Base and Competitors
Table 98. Akari Therapeutics Major Business
Table 99. Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 100. Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Akari Therapeutics Recent Developments/Updates
Table 102. Akari Therapeutics Competitive Strengths & Weaknesses
Table 103. Amgen Basic Information, Manufacturing Base and Competitors
Table 104. Amgen Major Business
Table 105. Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 106. Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Amgen Recent Developments/Updates
Table 108. Amgen Competitive Strengths & Weaknesses
Table 109. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 110. CSL Behring Major Business
Table 111. CSL Behring Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 112. CSL Behring Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. CSL Behring Recent Developments/Updates
Table 114. CSL Behring Competitive Strengths & Weaknesses
Table 115. Bioverativ Basic Information, Manufacturing Base and Competitors
Table 116. Bioverativ Major Business
Table 117. Bioverativ Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 118. Bioverativ Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Bioverativ Recent Developments/Updates
Table 120. Bioverativ Competitive Strengths & Weaknesses
Table 121. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 122. F. Hoffmann-La Roche Ltd Major Business
Table 123. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 124. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 126. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 127. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 128. Novartis AG Major Business
Table 129. Novartis AG Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 130. Novartis AG Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Novartis AG Recent Developments/Updates
Table 132. Novartis AG Competitive Strengths & Weaknesses
Table 133. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 134. Amgen Inc Major Business
Table 135. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 136. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Amgen Inc Recent Developments/Updates
Table 138. Amgen Inc Competitive Strengths & Weaknesses
Table 139. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. Teva Pharmaceutical Major Business
Table 141. Teva Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 142. Teva Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Teva Pharmaceutical Recent Developments/Updates
Table 144. Abbott Basic Information, Manufacturing Base and Competitors
Table 145. Abbott Major Business
Table 146. Abbott Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product and Services
Table 147. Abbott Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Upstream (Raw Materials)
Table 149. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Typical Customers
Table 150. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Typical Distributors
LIST OF FIGURE
Figure 1. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Picture
Figure 2. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2029) & (K Units)
Figure 5. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2029) & (K Units)
Figure 10. China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2018-2029) & (K Units)
Figure 12. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Markets in 2022
Figure 26. United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share 2022
Figure 32. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share by Type in 2022
Figure 34. Monoclonal Antibodies Therapy
Figure 35. Immunosuppressive Drugs
Figure 36. Hematopoietic Stem Cell Transplantation
Figure 37. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share by Type (2018-2029)
Figure 38. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share by Type (2018-2029)
Figure 39. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Clinic
Figure 44. Other
Figure 45. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Market Share by Application (2018-2029)
Figure 46. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Value Market Share by Application (2018-2029)
Figure 47. World Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Industry Chain
Figure 49. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Procurement Model
Figure 50. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Sales Model
Figure 51. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
